Date Field | Doc. No. | Party | Description |
---|
Dec 11, 2018 | 50 | | Updated Mandatory Notices (-01027) - remove K. Canfield as counsel Download |
Dec 4, 2017 | 49 | | Patent Owners' Notice of Appeal IPR2016-01027 Download |
Nov 8, 2017 | 48 | | Final Written Decision - Determining That Claim 1 Has Been Shown To Be Unpatentable Download |
Nov 2, 2017 | 3001 | | Parties (August 10th 2017) Email Construction Agreement Regarding the Term Core Matrix Download |
Oct 6, 2017 | 47 | | Hearing Transcript Download |
Sep 27, 2017 | 46 | | Petitioner's Updated Mandatory Notices Pursuant To 37 C.F.R. 42.8(a)(3) Download |
Jul 31, 2017 | 45 | | Petitioner's Updated Mandatory Notices Download |
Jul 26, 2017 | 43 | | Patent Owners' Demonstratives IPR2016-01027 Download |
Jul 26, 2017 | 44 | | Petitioner's Demonstratives for Oral Argument Download |
Jul 20, 2017 | 41 | | Patent Owners' Reply in Support of Motion to Exclude Download |
Jul 20, 2017 | 42 | | Reply To Patent Owners' Opposition To Petitioner's Motion To Exclude Evidence Download |
Jul 14, 2017 | 40 | | Patent Owners' Surreply IPR2016-01027 Download |
Jul 13, 2017 | 35 | | Patent Owners' Opposition to Motion to Exclude (2016-01027) Download |
Jul 13, 2017 | 39 | | Opposition to Patent Owners' Motion to Exclude Download |
Jul 13, 2017 | 38 | | Response to Patent Owners¿¿¿ Observations on Cross Examination of Dr. Robert J. Timko Download |
Jul 13, 2017 | 2150 | | 2150 Application No. 14728601 Jan 26 2017 Non Final Rejection Download |
Jul 13, 2017 | 2153 | | 2153 Application No. 14733659 Jan 18 2017 Non Final Rejection Download |
Jul 13, 2017 | 2154 | | 2154 Application No. 14733659 Final Rejection Download |
Jul 13, 2017 | 37 | | Response to Patent Owners¿¿¿ Observations on Cross Examination of Dr. Thomas Vander Veen Download |
Jul 13, 2017 | 36 | | Patent Owners' Updated Exhibit List (2016-01027) Download |
Jul 13, 2017 | 2152 | | 2152 Application No. 14733659 Dec 15 2016 RCE Download |
Jul 13, 2017 | 2151 | | 2151 Application No. 14728601 Final Rejection Download |
Jul 13, 2017 | 2149 | | 2149 Application No. 14728601 Dec 8 2016 RCE Download |
Jul 12, 2017 | 34 | | Patent Owners' Updated Mandatory Notice (-01027) Download |
Jul 7, 2017 | 33 | | Oral Hearing Order Download |
Jul 7, 2017 | 32 | | Order - re Conference Call (7/3/2017) Download |
Jun 30, 2017 | 2144 | | U.S. Patent Application No. 08/864,306 Download |
Jun 30, 2017 | 2145 | | Combined Declaration and Power of Attorney for U.S. Patent
Application No. 11/939,585 Download |
Jun 30, 2017 | 2146 | | U.S. Patent Application Publication No. 2008/0287418 Download |
Jun 30, 2017 | 2147 | | Deposition of Dr. Timko (June 22, 2017) Download |
Jun 30, 2017 | 2148 | | Deposition of Dr. Vander Veen (June 27, 2017) Download |
Jun 30, 2017 | 27 | | Patent Owners' Motion to Exclude Evidence Download |
Jun 30, 2017 | 28 | | Patent Owners' Updated Exhibit List Download |
Jun 30, 2017 | 29 | | Patent Owners' Observations on Timko Cross Examination Download |
Jun 30, 2017 | 30 | | Patent Owner - Observations on Vander Veen Cross-Examination Download |
Jun 30, 2017 | 31 | | Download |
Jun 29, 2017 | 26 | | PETITIONER¿¿¿S REQUEST FOR ORAL ARGUMENT Download |
Jun 29, 2017 | 25 | | Patent Owners' Request for Oral Hearing (IPR2016-01027) Download |
May 30, 2017 | 24 | | Patent Owners' Notice of Deposition of Dr. Vander Veen Download |
May 30, 2017 | 23 | | Patent Owners' Notice of Deposition of Dr. Timko Download |
May 25, 2017 | 1127 | | Purdue Pharma L.P. et al. v. Teva Pharmaceuticals LLC, No. 11-cv-2037 and 12-cv-5083 (S.D.N.Y. Jan. 14, 2014) Finding of Facts and Conclusion of Law Download |
May 25, 2017 | 22 | | Petitioner's Exhibit List Download |
May 22, 2017 | 21 | | Patent Owners' Objections to Evidence After Institution Download |
May 15, 2017 | 1109 | | U.S. Patent No. 7,776,314 Download |
May 15, 2017 | 1123 | | FDA Perspective on Assessment of Drugs Download |
May 15, 2017 | 1100 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations Download |
May 15, 2017 | 1103 | | Guha et al. Download |
May 15, 2017 | 1101 | | Chisum on Patents A Treatise on the Law of Patentability, Validity and Infringement Sect. 5.05, at 633-734 Download |
May 15, 2017 | 1115 | | U.S. Patent No. 9,492,389 Download |
May 15, 2017 | 1076 | | Remington, Ch. 94 - Sustained-Release Drug Delivery System Download |
May 15, 2017 | 1112 | | U.S. Patent No. 8,804,741 Download |
May 15, 2017 | 1108 | | Approved Drug Products with Therapeutic Equivalence Evaluations Download |
May 15, 2017 | 1104 | | Crouch, Objective Indicia on Non-Obviousness Must be Tied to Inventive Step Download |
May 15, 2017 | 1105 | | Kolassa, Elements of Pharmaceutical Pricing Download |
May 15, 2017 | 1075 | | Guidance for Industry: SUPAC-MR Download |
May 15, 2017 | 1120 | | Finding of Facts and Conclusion of Law, Purdue v. Teva Download |
May 15, 2017 | 1107 | | MPEP Sect. 716.03 Download |
May 15, 2017 | 1073 | | Meunier - Multicomponent Biopolymer Gels Download |
May 15, 2017 | 1118 | | U.S. Patent No. 9,492,393 Download |
May 15, 2017 | 1116 | | U.S. Patent No. 9,492,391 Download |
May 15, 2017 | 1125 | | Senator to investigate opioid makers¿¿¿ role in drug crisis Download |
May 15, 2017 | 1121 | | Center for Drug Evaluation and Research, Application Number 22 272 Download |
May 15, 2017 | 1110 | | U.S. Patent No. 8,114,383 Download |
May 15, 2017 | 1111 | | U.S. Patent No. 8,309,060 Download |
May 15, 2017 | 1074 | | Bailey et al., POLYOX, High Molecular Weight Polymers of Ethylene Oxide Download |
May 15, 2017 | 1117 | | U.S. Patent No. 9,492,392 Download |
May 15, 2017 | 1114 | | U.S. Patent No. 8,894,988 Download |
May 15, 2017 | 1106 | | Gunul et al., Promotion of Prescription Drugs and Its Impact on Physicians¿¿¿ Choice Behavior Download |
May 15, 2017 | 1113 | | U.S. Patent No. 8,894,987 Download |
May 15, 2017 | 1072 | | Zasypkin et al. Download |
May 15, 2017 | 20 | | Petitioner's Reply to Patent Owner's Response Download |
May 15, 2017 | 1122 | | Guidance for Industry: Abuse-Deterrent Opioids Evaluation and Labeling Download |
May 15, 2017 | 1102 | | Commercial Success: Economic Principles Applied to Patent Litigation, Ch. 9 Download |
May 15, 2017 | 1124 | | Advancements in Opioid Abuse Deterrence Download |
May 15, 2017 | 1119 | | Purdue Brief Download |
May 15, 2017 | 1126 | | Time for opioid makers to come clean and help addicts go clean Download |
May 15, 2017 | 1040 | | Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download |
May 15, 2017 | 1059 | | Follonier et al. Download |
May 15, 2017 | 1065 | | U.S. Patent No. 5,223,264 Download |
May 15, 2017 | 1070 | | Oxycodone, Merck Index 1194 (12 ed. 1996) Download |
May 15, 2017 | 1044 | | U.S. Patent No. 9,034,376 Download |
May 15, 2017 | 1064 | | U.S. Patent No. 3,822,343 Download |
May 15, 2017 | 1056 | | Chernug ju Kim, Effects of Drug Solubility, Drug Loading Download |
May 15, 2017 | 1040 | | Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download |
May 15, 2017 | 1062 | | U.S. Patent No. 5,266,331 Download |
May 15, 2017 | 1053 | | Dimitrov Download |
May 15, 2017 | 1052 | | Brunella Cappello et al. Download |
May 15, 2017 | 1069 | | Remington, Ch. 93 - Coating of Pharmaceutical Dosage Forms Download |
May 15, 2017 | 1060 | | Carstensen Download |
May 15, 2017 | 1066 | | Remington, Ch. 92 - Lubricants Download |
May 15, 2017 | 1041 | | Curriculum Vitae of Robert Timko, Ph.D. Download |
May 15, 2017 | 1067 | | U.S. Patent No. 5,948,437 Download |
May 15, 2017 | 1061 | | PDR Reference - REVIA, DILAUDID, TYLOX, TALWIN Download |
May 15, 2017 | 1068 | | Maniruzzaman et al. Download |
May 15, 2017 | 1051 | | Apicella et al. Download |
May 15, 2017 | 1042 | | Declaration of Dr. Thomas Vander Veen Download |
May 15, 2017 | 1057 | | Moroni and Ghebre Sellassie Download |
May 15, 2017 | 1055 | | Cherng ju Kim, Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets Download |
May 15, 2017 | 1043 | | Curriculum Vitae of Thomas Vander Veen, Ph.D. Download |
May 15, 2017 | 1054 | | Efentakis Download |
May 15, 2017 | 1063 | | U.S. Patent No. 5,178,878 Download |
May 15, 2017 | 1058 | | Yang et al. Download |
May 15, 2017 | 1040 | | Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download |
May 5, 2017 | 19 | | Notice of Joint Stipulation to Modify Due Dates 2 and 4 Download |
Feb 15, 2017 | 18 | | PETITIONER¿¿¿S OBJECTIONS UNDER 37 C.F.R. ¿¿ 42.64 TO EVIDENCE SUBMITTED BY PATENT OWNERS POST-INSTITUTION Download |
Feb 8, 2017 | 2122 | | 2122 Kim - 84 J Pharm Sci 303 Download |
Feb 8, 2017 | 2139 | | 2139 Thompson - 58 Am Jnl of Health-System Pharmacy 956 Download |
Feb 8, 2017 | 2123 | | 2123 Madorsky - 36 J Polym Sci 183 Download |
Feb 8, 2017 | 2143 | | 2143 Baker - Controlled Release of Biologically Active Agents (1987) Download |
Feb 8, 2017 | 2100 | | 2100 U.S. Patent No. 5,508,042 Download |
Feb 8, 2017 | 2129 | | 2129 U.S. Patent No. 6,177,567 Download |
Feb 8, 2017 | 2132 | | 2132 Handbook of Pharmaceutical (Magnesium Stearate) Download |
Feb 8, 2017 | 2098 | | 2098 Wright Declaration in Support of Patent Owner Response Download |
Feb 8, 2017 | 2131 | | 2131 Craig - 179 Int'l. J. Pharm. 179 Download |
Feb 8, 2017 | 2113 | | 2113 Zhang - 4 Pharm Dev Technol 241 Download |
Feb 8, 2017 | 2102 | | 2102 U.S. Patent No. 5,266,331 Download |
Feb 8, 2017 | 2136 | | 2136 Downie - 7 Hospital Pharmacist 242 Download |
Feb 8, 2017 | 2099 | | 2099 Deposition of Dr. Palmieri (January 13, 2017) Download |
Feb 8, 2017 | 2112 | | 2112 FDA Guidance for Industry 1997 Download |
Feb 8, 2017 | 2137 | | 2137 Brookoff - 8 Jnl of General Internal Medicine 688 Download |
Feb 8, 2017 | 2135 | | 2135 Bossert - 6 Drug Dev. + Indus. Pharm. 573 Download |
Feb 8, 2017 | 2110 | | 2110 Coplan - 100 Clin Pharm Therap 275 Download |
Feb 8, 2017 | 2103 | | 2103 U.S. Patent No. 5,656,295 Download |
Feb 8, 2017 | 2097 | | 2097 Oshlack Declaration in Support of Patent Owner Response Download |
Feb 8, 2017 | 2128 | | 2128 Salomies - 83 J AOAC Int'l 1497 Download |
Feb 8, 2017 | 17 | | Patent Owners' Response to Petition for Inter Partes Review Download |
Feb 8, 2017 | 2109 | | 2109 Severtson - 168 Drug and Alcohol Dep 219 Download |
Feb 8, 2017 | 2125 | | 2125 Alderman - 5 In¿¿¿l J. Pharm. Tech. Prod. Mfr. 1 Download |
Feb 8, 2017 | 2133 | | 2133 Ragnarsson - 3 Int'l. J. Pharm. 127 Download |
Feb 8, 2017 | 2111 | | 2111 Frederichs - Opioids overview Buschmann, Friderichs 2002 Download |
Feb 8, 2017 | 2134 | | 2134 Murthy - 66 J Pharm Sci 1215 Download |
Feb 8, 2017 | 2114 | | 2114 Zhang - 26 Drug Dev Ind Pharm 931 Download |
Feb 8, 2017 | 2096 | | 2096 Byrn Declaration ISO Patent Owner Response to Petition Download |
Feb 8, 2017 | 2115 | | 2115 McGinity - 4 Am Pharm Rev 25 Download |
Feb 8, 2017 | 2130 | | 2130 Brogle - 19 J. Pharm and Biomed. Analysis 669 Download |
Feb 8, 2017 | 16 | | Patent Owners' Motion to Seal Download |
Feb 8, 2017 | 2127 | | 2127 Poyhia - 8 Jnl of Pain and Symptom Mgmt 63 Download |
Feb 8, 2017 | 2118 | | 2118 Crowley - 23 Biomaterials 4241 Download |
Feb 8, 2017 | 2138 | | 2138 Chernin - Painkillers and Pill Popping Download |
Feb 8, 2017 | 2095 | | 2095 HPE 3rd ed (2000) TOC and Index Download |
Feb 8, 2017 | 2124 | | 2124 McGary - 46 J Polym Sci 51 Download |
Feb 8, 2017 | 2116 | | 2116 Follonier - 20 Drug Dev Ind Pharm 1323 Download |
Feb 8, 2017 | 2141 | | 2141 U.S. Patent No. 6,067,749 Download |
Feb 8, 2017 | 2142 | | 2142 Byrn - Solid State Acid Base Reactions Download |
Feb 8, 2017 | 2101 | | 2101 U.S. Patent No. 5,549,912 Download |
Feb 8, 2017 | 2140 | | 2140 Letter to Pablo Hendler Download |
Nov 15, 2016 | 15 | | Joint Motion for Entry of Stipulated Protective Order Download |
Nov 9, 2016 | 13 | | Decision - Institution of Inter Partes Review Download |
Nov 9, 2016 | 14 | | Scheduling Order Download |
Aug 31, 2016 | 12 | | Order - Patent Owner's Motions for Pro Hac Vice Admission Download |
Aug 12, 2016 | 2046 | | 2046 ADFs-A Tale of Two ADFs-TJ Cicero Pain 2016 Download |
Aug 12, 2016 | 2004 | | 2004 '324 FH IDS 2013-06-05 Download |
Aug 12, 2016 | 2051 | | 2051 FDA approves abuse-deterrent labeling for reformulated OxyContin Download |
Aug 12, 2016 | 2054 | | 2054 Actavis press release Download |
Aug 12, 2016 | 2033 | | 2033 Throckmorton, FDA Voice Download |
Aug 12, 2016 | 2055 | | 2055 Endo to FDA, Opana reformulation citizen petition Download |
Aug 12, 2016 | 2068 | | 2068 2014.03.11 Xartemis XR Download |
Aug 12, 2016 | 2047 | | 2047 FDA Statement Original Opana ER Relisting Determination Download |
Aug 12, 2016 | 2059 | | 2059 2011.04.20 Opana ER Download |
Aug 12, 2016 | 2069 | | 2069 2012.07.09 Avinza Download |
Aug 12, 2016 | 2078 | | 2078 2015.04 Generic methadone HCl tablet Download |
Aug 12, 2016 | 2034 | | 2034 14-733,659 FH NOA 2016-08-01 Download |
Aug 12, 2016 | 2009 | | 2009 '324 FH Comments on 2nd NOA 2015-05-18 Download |
Aug 12, 2016 | 2073 | | 2073 2012.07.09 Dolophine Download |
Aug 12, 2016 | 2012 | | 2012 CPDD Paper 2003 Download |
Aug 12, 2016 | 2006 | | 2006 '324 FH Eaminer Refs 2015-05-12 Download |
Aug 12, 2016 | 2023 | | 2023 Joshi WO_2002_087558_A1 Download |
Aug 12, 2016 | 2045 | | 2045 2012 Endo press release announcing reformulation Download |
Aug 12, 2016 | 2027 | | 2027 QOS 10-40mg (excerpt) Download |
Aug 12, 2016 | 2057 | | 2057 2010.04.05 Oxycontin Download |
Aug 12, 2016 | 2020 | | 2020 MW 'core' 2001 Download |
Aug 12, 2016 | 2041 | | 2041 PUBLIC Expert Declaration of Eric M. Gaier PhD_Redacted (2) Download |
Aug 12, 2016 | 2091 | | 2091 PDR 1997 Download |
Aug 12, 2016 | 2024 | | 2024 CPDD Article - author info Download |
Aug 12, 2016 | 2090 | | 2090 UCM187629 2009 AdComm Minutes Download |
Aug 12, 2016 | 2089 | | 2089 UCM183205 2009 AdComm FDA briefing doc Download |
Aug 12, 2016 | 2002 | | 2002 '324 FH Misc. Action 2014-04-07 Download |
Aug 12, 2016 | 2016 | | 2016 OxyContin labeling 4-2013 Download |
Aug 12, 2016 | 2035 | | 2035 HPE-3rd Gelling agents Download |
Aug 12, 2016 | 2048 | | 2048 Chou 2009, Clinical Guidelines for the Use of Chronic Opioid Therapy Download |
Aug 12, 2016 | 2021 | | 2021 '324 FH IDS 2015-01-05 Download |
Aug 12, 2016 | 2031 | | 2031 Scheirs, Solid state degradation of PEO Download |
Aug 12, 2016 | 2022 | | 2022 '324 FH Examiner Refs 2015-05-12 Download |
Aug 12, 2016 | 2037 | | 2037 HPE-3rd Plasticizers Download |
Aug 12, 2016 | 2093 | | 2093 Wright Testimony Download |
Aug 12, 2016 | 2088 | | 2088 Sept. 2009 Purdue AdCom slides Download |
Aug 12, 2016 | 2058 | | 2058 2010.06.30 Butrans Approval Download |
Aug 12, 2016 | 2081 | | 2081 2004.03.24 Generic oxycodone ER Download |
Aug 12, 2016 | 2071 | | 2071 2008.02.20 Ultram ER Download |
Aug 12, 2016 | 2064 | | 2064 2007.04.20 Kadian Download |
Aug 12, 2016 | 2070 | | 2070 2010.05.11 MS Contin Download |
Aug 12, 2016 | 2082 | | 2082 Generic Hydromorpohone HCl ER Download |
Aug 12, 2016 | 2061 | | 2061 2009.07.31 Duragesic Download |
Aug 12, 2016 | 2011 | | 2011 14-728,601 FH NOA 2016-03-10 Download |
Aug 12, 2016 | 2072 | | 2072 2014.04 Methadose tablet Download |
Aug 12, 2016 | 2039 | | 2039 Maurin Testimony Download |
Aug 12, 2016 | 2086 | | 2086 May 2008 AdComm minutes Download |
Aug 12, 2016 | 2083 | | 2083 Sessler et al 2014, Reductions in reported deaths following the... Download |
Aug 12, 2016 | 2085 | | 2085 C8275 OXY field card Download |
Aug 12, 2016 | 2038 | | 2038 Merck Index Download |
Aug 12, 2016 | 2014 | | 2014 Cicero 2016 Download |
Aug 12, 2016 | 2029 | | 2029 PolyOx brochure Download |
Aug 12, 2016 | 2040 | | 2040 5549912 Download |
Aug 12, 2016 | 2015 | | 2015 UCM332288 (FDA opioid timeline) Download |
Aug 12, 2016 | 2074 | | 2074 2007.05 Oramorph SR Download |
Aug 12, 2016 | 2094 | | 2094 Proposed Protective Order (1027) Download |
Aug 12, 2016 | 2036 | | 2036 HPE-3rd Lubricants Download |
Aug 12, 2016 | 2005 | | 2005 '324 FH Examiner Refs 2013-07-09 Download |
Aug 12, 2016 | 2018 | | 2018 Levina, Effect of drug and excipients on release Download |
Aug 12, 2016 | 2008 | | 2008 OxyContin labeling 8-2015 Download |
Aug 12, 2016 | 2063 | | 2063 2013.10.25 Zohydro ER Download |
Aug 12, 2016 | 2079 | | 2079 2015.10.20 Generic Tramadol HCl ER Download |
Aug 12, 2016 | 2030 | | 2030 Attorneys General letter Download |
Aug 12, 2016 | 2080 | | 2080 2014.04.16 Generic oxymorphone HCl Download |
Aug 12, 2016 | 2092 | | 2092 Oshlack Testimony Download |
Aug 12, 2016 | 9 | | IPR2016-01027 Preliminary Response Download |
Aug 12, 2016 | 2076 | | 2076 1998.07.02 Generic morphine sulfate Download |
Aug 12, 2016 | 2065 | | 2065 2010.03.01 Exalgo Download |
Aug 12, 2016 | 2019 | | 2019 Vazquez, Influence of technological variables on release of drugs... Download |
Aug 12, 2016 | 2007 | | 2007 Byrn Declaration Download |
Aug 12, 2016 | 2032 | | 2032 Abuse-Deterrent Opioids draft guidance Download |
Aug 12, 2016 | 2075 | | 2075 2008.12.30 Ryzolt Download |
Aug 12, 2016 | 2017 | | 2017 FDA Determination 2013-04-16 Download |
Aug 12, 2016 | 2067 | | 2067 2010.05.07 Conzip Download |
Aug 12, 2016 | 2010 | | 2010 '449 FH Amendment 2012-10-01 Download |
Aug 12, 2016 | 11 | | Patent Owner's Exhibit List 2016-08-12 Download |
Aug 12, 2016 | 2028 | | 2028 QOS 60-80mg (excerpt) Download |
Aug 12, 2016 | 2062 | | 2062 2014.11.20 Hysingla ER Download |
Aug 12, 2016 | 2025 | | 2025 FDA Devel. Reg. Abuse-Deterrent Opioid 2014-10-30 Download |
Aug 12, 2016 | 2066 | | 2066 2009.08.13 Embeda Download |
Aug 12, 2016 | 2077 | | 2077 2014.05 Generic fentanyl patch Download |
Aug 12, 2016 | 2001 | | 2001 Interference 106,004 Request Adverse Judgment Download |
Aug 12, 2016 | 2060 | | 2060 2011.08.25 Nucynta ER Download |
Aug 12, 2016 | 2084 | | 2084 0PO571 (C8559) Download |
Aug 12, 2016 | 2052 | | 2052 Endo announces Opana first launch Download |
Aug 12, 2016 | 2003 | | 2003 Interference 106,004 Judgment Download |
Aug 12, 2016 | 2087 | | 2087 Weingarten Testimony Download |
Aug 12, 2016 | 2053 | | 2053 Butler 2013, Abuse rates and routes Download |
Aug 12, 2016 | 2049 | | 2049 FDA orange book Download |
Aug 12, 2016 | 10 | | IPR2016-01027 Patent Owner's Motion To Seal Download |
Jun 14, 2016 | 7 | patent_own | Amneal IPR - Normile Pro Hac Motion (IPR2016-01027) Download |
Jun 14, 2016 | 8 | patent_own | Amneal IPR - Winchester Pro Hac Motion (IPR2016-01027) Download |
May 31, 2016 | 6 | patent_own | Amneal IPR - Mandatory Notices (IPR2016-01027) Download |
May 27, 2016 | 5 | potential_ | Power of Attorney Download |
May 12, 2016 | 4 | board | Notice of Filing Date Accorded to Petition Download |
May 11, 2016 | 3 | petitioner | Power of Attorney Download |
May 11, 2016 | 2 | petitioner | Petition for Inter Partes Review of U.S. Patent No. 9,060,976 Download |
May 11, 2016 | 1007 | petitioner | Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download |
May 11, 2016 | 1015 | petitioner | International Publication No. WO 95/20947 Download |
May 11, 2016 | 1014 | petitioner | U.S. Patent Publication No. 2002/0187192 Download |
May 11, 2016 | 1025 | petitioner | Serial No. 10/214,412 Download |
May 11, 2016 | 1037 | petitioner | U.S. Patent No. 4,861,598 (Oshlack) Download |
May 11, 2016 | 1019 | petitioner | Barry Meier, U.S. Asks Painkiller Maker To Help Curb Wide Abuse Download |
May 11, 2016 | 1028 | petitioner | Serial No. 13/726,324, Preliminary Amendment, Dec. 24, 2012 Download |
May 11, 2016 | 1022 | petitioner | Serial No. 13/726,324 Download |
May 11, 2016 | 1020 | petitioner | Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Download |
May 11, 2016 | 1039 | petitioner | Oral Dosage Forms II (94) Remington The Science and Practice of Pharmacy Download |
May 11, 2016 | 1030 | petitioner | Serial No. 13/726,324, Office Action, July 15, 2013 Download |
May 11, 2016 | 1013 | petitioner | International Publication No. WO 97/49384 Download |
May 11, 2016 | 1016 | petitioner | OxyContin, Physicians Desk Reference 2569-74 Download |
May 11, 2016 | 1005 | petitioner | U.S. Patent No. 8,101,630 Download |
May 11, 2016 | 1033 | petitioner | Serial No. 13/726,324, Request for Continued Examination, Jan. 5, 2015 Download |
May 11, 2016 | 1034 | petitioner | Serial No. 13/726,324, Communication from Applicant, Jan. 29, 2015 Download |
May 11, 2016 | 1008 | petitioner | Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download |
May 11, 2016 | 1021 | petitioner | Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Download |
May 11, 2016 | 1036 | petitioner | Serial No. 13/726,324, Notice of Allowance, May 12, 2015 Download |
May 11, 2016 | 1032 | petitioner | Serial No. 13/726,324, Notice of Allowance, Oct. 31, 2014 Download |
May 11, 2016 | 1012 | petitioner | The Handbook of Pharmaceutical Excipients 399-400, 655 Download |
May 11, 2016 | 1001 | petitioner | U.S. Patent No. 9,060,976 Download |
May 11, 2016 | 1006 | petitioner | U.S. Patent Publication No. 2010/0216829 Download |
May 11, 2016 | 1038 | petitioner | U.S. Provisional Patent Application No. 60/287,509 Download |
May 11, 2016 | 1010 | petitioner | Curriculum Vitae of Anthony Palmieri, Ph.D. Download |
May 11, 2016 | 1 | petitioner | Transmittal letter regarding exhibits Download |
May 11, 2016 | 1002 | petitioner | U.S. Patent No. 8,337,888 Download |
May 11, 2016 | 1024 | petitioner | Serial No. 12/653,115 Download |
May 11, 2016 | 1009 | petitioner | Declaration of Dr. Anthony Palmieri Download |
May 11, 2016 | 1011 | petitioner | International Publication Download |
May 11, 2016 | 1018 | petitioner | Department of Justice, Information Bulletin Download |
May 11, 2016 | 1003 | petitioner | Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, Download |
May 11, 2016 | 1004 | petitioner | Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download |
May 11, 2016 | 1026 | petitioner | U.S. Provisional Patent Application No. 60/310,534 Download |
May 11, 2016 | 1029 | petitioner | Serial No. 13/726,324, Supplemental Amendment, Jan. 23, 2013 Download |
May 11, 2016 | 1035 | petitioner | Serial No. 13/726,324, Information Disclosure Statement, Apr. 14, 2015 Download |
May 11, 2016 | 1023 | petitioner | Serial No. 13/349,449 Download |
May 11, 2016 | 1031 | petitioner | Serial No. 13/726,324, Amendment and Response, Jan. 15, 2014 Download |
May 11, 2016 | 1017 | petitioner | Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC 2014-1306 Download |